Search
JD Health CEO: Over 20 Global Pharma and Health Brands, Including Pfizer, Merck, and Novo, to Sign Contracts; More Than 100 New Drugs Debuted Online in First Three Quarters
4 day ago /
Read about 0 minute
Author：小编
On November 5, the 9th China International Import Expo (CIIE) opened in Shanghai. During the event, JD Health CEO Cao Dong announced that JD Health will sign centralized contracts with more than 20 global pharmaceutical and health brands at this year's CIIE, including Pfizer, Merck, Novo, Takeda, Boehringer Ingelheim, Haleon Sino-American Tianjin Smith Kline & French Laboratories, Novartis, and LEO Pharma. JD Health has already established deep partnerships with 50 leading multinational pharmaceutical companies worldwide. As of the first three quarters of 2026, JD Health has debuted more than 100 new drugs online, surpassing the total for all of last year.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
